{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:43:19Z","timestamp":1790134999237,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.neuroscience.2012.02.004","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T00:29:46Z","timestamp":1328833786000},"page":"85-96","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Long-term polarization of microglia upon \u03b1-synuclein overexpression in nonhuman primates"],"prefix":"10.1016","volume":"208","author":[{"given":"P.","family":"Barkholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sanchez-Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Romero-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.02.004_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib2","first-page":"253","article-title":"Increase of secondary processes of microglial and astroglial cells after MPTP-induced degeneration in substantia nigra pars compacta of non human primates","author":"Barcia","year":"2009","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2004.02.026","article-title":"Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background","volume":"26","author":"Cabin","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib6","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib9","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/brain\/awl382","article-title":"Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain","volume":"130","author":"Eslamboli","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","article-title":"Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts","volume":"121","author":"Fellner","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","article-title":"Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice","volume":"24","author":"Gomez-Isla","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"Pt 3","key":"10.1016\/j.neuroscience.2012.02.004_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J Microsc"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2012.02.004_bib17","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1016\/S1353-8020(11)70067-0","article-title":"Immunization strategies for Parkinson's disease","volume":"18","author":"Ha","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0014-4886(03)00273-5","article-title":"Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys","volume":"184","author":"Hurley","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/glia.10149","article-title":"Intracellular signaling in M-CSF-induced microglia activation: role of Iba1","volume":"40","author":"Imai","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-4-2","article-title":"Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein","volume":"4","author":"Jin","year":"2007","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/glia.20690","article-title":"Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys","volume":"56","author":"Kanaan","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neurobiolaging.2008.07.006","article-title":"Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys","volume":"31","author":"Kanaan","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib25","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1471-4159.2009.06075.x","article-title":"Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP","volume":"109","author":"Kim","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jnr.20562","article-title":"Microglia in health and disease","volume":"81","author":"Kim","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib27","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib28","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2009.12.009","article-title":"Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain","volume":"222","author":"Kornum","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib33","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","article-title":"Clearance and deposition of extracellular alpha-synuclein aggregates in microglia","volume":"372","author":"Lee","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib36","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2012.02.004_bib38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005072-199603000-00014","article-title":"Immunohistochemical localization of extracellular matrix proteins in cerebral vessels in chronic hypertension","volume":"55","author":"Nag","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib41","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib43","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib44","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1046\/j.1471-4159.2003.02213.x","article-title":"Microglia\/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity","volume":"88","author":"Ohsawa","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib45","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson's disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.20691","article-title":"Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease","volume":"56","author":"Park","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib48","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib49","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","article-title":"Immunological features of alpha-synuclein in Parkinson's disease","volume":"12","author":"Roodveldt","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib50","doi-asserted-by":"crossref","first-page":"e13481","DOI":"10.1371\/journal.pone.0013481","article-title":"Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants","volume":"5","author":"Roodveldt","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib51","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib54","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib55","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib56","series-title":"The brain of the common marmoset (Callathrix jacchus)","author":"Stephan","year":"1980"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-0082(98)00069-0","article-title":"Reactive microgliosis","volume":"57","author":"Streit","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":") Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib59","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","article-title":"Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system","volume":"16","author":"Tomas-Camardiel","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib62","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib63","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/NEN.0b013e3181b35e41","article-title":"Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys","volume":"68","author":"Vazquez-Claverie","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib64","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1523\/JNEUROSCI.4363-08.2009","article-title":"Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals","volume":"29","author":"Wake","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2008.09.013","article-title":"Molecular mechanisms of alpha-synuclein neurodegeneration","volume":"1792","author":"Waxman","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/104303401300042500","article-title":"CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice","volume":"12","author":"Xu","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib71","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.70.7.4646-4654.1996","article-title":"A \u201chumanized\u201d green fluorescent protein cDNA adapted for high-level expression in mammalian cells","volume":"70","author":"Zolotukhin","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.neuroscience.2012.02.004_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T01:59:55Z","timestamp":1593655195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":72,"alternative-id":["S0306452212001078"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.02.004","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}